Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease
Medical Science Monitor · 2024
DOI: 10.12659/msm.944314 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Hsin Hsiang Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Febuxostat, Allopurinol, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Research, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Medicine, Fu Jen Catholic University School of Medicine, New Taipei City, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan.
Zitieren
APA
Huang, H. H., Chen, Y. Y., Fang, Y. W., Liou, H. H., Wang, J. T., & Tsai, M. H. (2024). Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease. Medical Science Monitor. https://doi.org/10.12659/msm.944314
Vancouver
Huang HH, Chen YY, Fang YW, Liou HH, Wang JT, Tsai MH. Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease. Medical Science Monitor. 2024. doi:10.12659/msm.944314
BibTeX
@article{Huang2024,
author = {Huang, Hsin Hsiang and Chen, Yun-Yi and Fang, Yu-Wei and Liou, Hung-Hsiang and Wang, Jing-Tong and Tsai, Ming-Hsein},
title = {Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease},
journal = {Medical Science Monitor},
year = {2024},
doi = {10.12659/msm.944314}
}
EUVIMED